Publications by authors named "YuFeng Xing"

Claim this Profile
J
Joint association of inflammatory markers and sedentary time with mortality in metabolic dysfunction-associated steatotic liver disease population and the mediating role of inflammation.
Liu-Bin Xu, Xin-Yu Hu, Hui-Li Yang, Lian Feng, Jing Chen, Yu-Feng Xing

Eur J Med Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic inferior mesenteric arteriovenous fistula with bleeding diarrhea: A case report.
Congcong Shi, Xuan Zheng, Lihong Chen, Shenfeng Wu, Ziyou Zhong, Yufeng Xing

Medicine (Baltimore)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shugan Xiaozhi Decoction attenuates nonalcoholic steatohepatitis by modulating oxidative stress and AMPK pathway.
Rong Yang, Lian Feng, Zhijian Gong, Huili Yang, Haiyan Du, Yufeng Xing

BMC Complement Med Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferior mesenteric arteriovenous fistula: Progress in diagnosis and management.
Congcong Shi, Lihong Chen, Ziyou Zhong, Jing Chen, Zhijian Gong, Yufeng Xing

Medicine (Baltimore)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network Pharmacology and Molecular Docking Integrated with Molecular Dynamics Simulations Investigate the Pharmacological Mechanism of Yinchenhao Decoction in the Treatment of Non-alcoholic Fatty Liver Disease.
Rong Yang, Dansheng Jiang, Hongling Xu, Huili Yang, Lian Feng, Yufeng Xing

Curr Comput Aided Drug Des· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROS-responsive injectable hydrogels loaded with exosomes carrying miR-4500 reverse liver fibrosis.
Huili Yang, Wanshun Wang, Jiacong Xiao, Rong Yang, Lian Feng, Yufeng Xing

Biomaterials· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvianolic acid C promotes renal gluconeogenesis in fibrotic kidneys through PGC1α.
Yufeng Xing, Di Huang, Pinglan Lin, Yijing Zhou, Dongping Chen

Biochem Biophys Res Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: A large gastric calcifying fibrous tumor treated with endoscopic submucosal excavation.
Ziyou Zhong, Zhenguo Li, Yufeng Xing, Shaoju Guo

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients.
Furong Huang, Bo Lyu, Fanci Xie, Fang Li, Yufeng Xing

Front Microbiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competitive adsorption of microRNA-532-3p by circular RNA SOD2 activates Thioredoxin Interacting Protein/NLR family pyrin domain containing 3 pathway and promotes pyroptosis of non-alcoholic fatty hepatocytes.
FengJuan Chen, YuFeng Xing, ZhiJie Chen, XiaoMan Chen, Jie Li

Eur J Med Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Woman with epigastric pain after massage.
Ziyou Zhong, Yufeng Xing, Yabin Wu, Shaoju Guo

J Am Coll Emerg Physicians Open· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A classical herbal formula alleviates high-fat diet induced nonalcoholic steatohepatitis (NASH) via targeting mitophagy to rehabilitate dysfunctional mitochondria, validated by UPLC-HRMS identification combined with in vivo experiment.
Mingtai Chen, Furong Huang, Bohao Chen, Junli Kang, Yijing Yao, Yufeng Xing

Biomed Pharmacother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hirudin ameliorates diabetic nephropathy by inhibiting Gsdmd-mediated pyroptosis.
Jiarui Han, Zhenkui Zuo, Xiujie Shi, Yage Zhang, Zining Peng, Yufeng Xing

Cell Biol Toxicol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Potential TMPRSS2 Inhibitors for COVID-19 Treatment in Chinese Medicine by Computational Approaches and Surface Plasmon Resonance Technology.
Rong Yang, Linhua Liu, Dansheng Jiang, Lei Liu, Huili Yang, Yufeng Xing

J Chem Inf Model· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trial.
Yufeng Xing, Weichao Zhong, Deti Peng, Zhiyi Han, Hua Zeng

Pharmacol Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model.
Shuo Li, Zhiguo Li, Hongbo Du, Xiaobin Zao, Da'nan Gan, Yufeng Xing

Front Public Health· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
Rong Yang, Huili Yang, Dansheng Jiang, Linyi Xu, Lian Feng, Yufeng Xing

PeerJ· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A flexoelectricity-enabled ultrahigh piezoelectric effect of a polymeric composite foam as a strain-gradient electric generator.
Dongze Yan, Jianxiang Wang, Jinwu Xiang, Yufeng Xing, Li-Hua Shao

Sci Adv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of acetyl-CoA carboxylase (ACC) inhibitors in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review.
Liubin Xu, Huili Yang, Hongling Xu, Rong Yang, Lian Fen, Yufeng Xing

Medicine (Baltimore)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model.
Lidan Luo, Shuai Wang, Bohao Chen, Mei Zhong, Ruili Du, Yufeng Xing

Front Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis.
Huili Yang, Lian Feng, Linyi Xu, Dansheng Jiang, Fenfen Zhai, Yufeng Xing

Biomed Res Int· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note to: Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma.
Chuantao Zhang, Jianxiang Liu, Zhiyi Han, Xiang Cui, Deti Peng, Yufeng Xing

Int J Clin Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis.
Mingtai Chen, Ying Xie, Shenglan Gong, Yunqiao Wang, Hao Yu, Yufeng Xing

Pharmacol Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase Levels.
Xiaoke Li, Yufeng Xing, Daqiao Zhou, Huanming Xiao, Zhenhua Zhou

Front Med (Lausanne)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The deficiency of FKBP-5 inhibited hepatocellular progression by increasing the infiltration of distinct immune cells and inhibiting obesity-associated gut microbial metabolite.
Chuantao Zhang, Xiang Cui, Lian Feng, Zhiyi Han, Deti Peng, Yufeng Xing

J Gastrointest Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis